血管内皮生长因子（VEGF）及其受体

Sino biological offers a comprehensive set of tools for vascular endothelial growth factor (VEGF) related research.

These high-quality reagents include:

Product Categories / Species	Human	Mouse	Rat	Dog
Recombinant Proteins	9	1	-	-
Antibodies	9	-	-	-
ORF cDNA Clones	7	5	1	1

血管内皮生长因子（VEGF）及其受体产品

请点击以下您感兴趣的分子，查看具体产品

_* 新产品即将上线.

Neuropilin-1	VEGF-B ^*	VEGFR1 / FLT1 ^*
PIGF ^*	VEGF-C	VEGFR2 / Flk-1
VEGF / VEGF-A	VEGF-D / FIGF	VEGFR3 / FLT-4

血管内皮生长因子（VEGF）及其受体背景综述

Vascular endothelial growth factors (VEGFs) constitute a sub-family of growth factors that stimulate the growth of new blood vessels. Vascular endothelial growth factors are important signaling proteins involved in both vasculogenesis (the de novo formation of the embryonic circulatory system) and angiogenesis (the growth of blood vessels from pre-existing vasculature). VEGF-A is the first member of the vascular endothelial growth factor family, which also include VEGF-B, VEGF-C, VEGF-D, and placenta growth factor (PlGF). VEGF-A was called just VEGF before discovery of the other members. Vascular endothelial growth factors are key mediators of angiogenesis that is crucial for development and metastasis of tumors. The importance of VEGFs in tumorigenesis and tumor progression makes them attractive targets for the development of anticancer therapies. Previous studies have implicated single nucleotide polymorphisms (SNP) in the VEGF gene as predictive and prognostic markers for major solid tumors, including the breast, non-small cell lung, colorectal, and prostate cancers.

血管内皮生长因子（VEGF）及其受体参考文献

Holmes K, et al. (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal. 19(10) 2003-12.
Jain L, et al. (2009) The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther. 8(9):2496-508.
Wu LM, et al. (2009) A single nucleotide polymorphism in the vascular endothelial growth factor gene is associated with recurrence of hepatocellular carcinoma after transplantation. Arch Med Res. 40(7):565-70.